Nurix Therapeutics, Inc. (NRIX)
25.78
-0.43
(-1.64%)
USD |
NASDAQ |
Aug 31, 16:00
25.82
+0.04
(+0.16%)
After-Hours: 20:00
Nurix Therapeutics Cash from Operations (Annual) : -249.46M for Nov. 30, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| November 30, 2025 | -249.46M |
| November 30, 2024 | -172.58M |
| November 30, 2023 | -81.36M |
| November 30, 2022 | -159.81M |
| Date | Value |
|---|---|
| November 30, 2021 | -84.36M |
| November 30, 2020 | -0.08M |
| November 30, 2019 | 0.601M |
| November 30, 2018 | -31.68M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Monte Rosa Therapeutics, Inc. | -22.80M |
| Gilead Sciences, Inc. | 10.02B |
| TG Therapeutics, Inc. | -24.77M |
| Cue Biopharma, Inc. | -21.69M |
| Keros Therapeutics, Inc. | 107.50M |